Location History:
- Therwill, CH (2018)
- Therwil, CH (2016 - 2020)
Company Filing History:
9 out of 72 
1 out of 63 
Years Active: 2016-2020
Title: Inventor Heidi Alexandra Lane: Pioneering Drug Response Biomarkers
Heidi Alexandra Lane is a renowned inventor based in Therwil, Switzerland, known for her groundbreaking contributions to the field of pharmacology and biomarker research. With a total of nine patents to her name, Lane's work focuses primarily on the use of specific biomarkers to predict drug responses, particularly in the context of neoplastic and autoimmune diseases.
Latest Patents
Among her latest patents, Lane has developed methods utilizing phospho-Akt as a biomarker of drug response. This innovative approach involves predicting resistance to a compound involving phosphorylated Akt, while also detailing specific conditions for its application. Additionally, she has worked on the use of glu-tubulin as a similar biomarker for furazanobenzimidazoles, aimed at determining the response of cancer patients to this class of compounds. These contributions not only advance the understanding of drug mechanisms but also hold the potential for more effective treatment strategies.
Career Highlights
Over her career, Lane has worked for notable companies, including Basilea Pharmaceutica AG and Ruprecht-Karls-Universität Heidelberg. Her experiences in these esteemed institutions have greatly influenced her research direction and innovation. With a strong academic and practical foundation, Lane continues to make significant strides in the pharmaceutical industry.
Collaborations
Throughout her career, Lane has collaborated with distinguished colleagues such as Felix Bachmann and Madlaina Breuleux. These partnerships have fostered an environment of knowledge sharing and have likely propelled further advancements in her research on drug response biomarkers.
Conclusion
Heidi Alexandra Lane remains a pivotal figure in the realm of biomarker research, with her innovative patents highlighting her commitment to improving drug efficacy and patient outcomes. As she continues to explore new horizons in pharmacology, her contributions will surely provide lasting impacts in the healthcare field.